BrainStorm Cell Therapeutics
BCLI
#10412
Rank
$5.95 M
Marketcap
$0.54
Share price
-3.57%
Change (1 day)
-73.27%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Cash on Hand

Cash on Hand as of September 2025 : $0 Million USD

According to BrainStorm Cell Therapeutics's latest financial reports the company has $0 Million USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BrainStorm Cell Therapeutics - Cash on Hand chart (from 2002 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$0.18 M-85.62%
2023-12-31$1.3 M-56.42%
2022-12-31$2.98 M-86.5%
2021-12-31$22.09 M-47.31%
2020-12-31$41.93 M7270.12%
2019-12-31$0.56 M-91.95%
2018-12-31$7.06 M-8.92%
2017-12-31$7.75 M-22.36%
2016-12-31$9.99 M-37.39%
2015-12-31$15.95 M86.8%
2014-12-31$8.54 M143.82%
2013-12-31$3.5 M-14.27%
2012-12-31$4.08 M112.48%
2011-12-31$1.92 M1967.74%
2010-12-31$0.09 M9200%
2009-12-31$0 M-50%
2008-12-31$0 M-97.67%
2007-12-31$0.08 M43.33%
2006-12-31$0.06 M
2006-03-31$0.29 M-44.88%
2005-03-31$0.52 M11336.12%
2004-03-31$0 M-53.94%
2003-03-31$0 M-72.35%
2002-03-31$0.03 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Gilead Sciences
GILD
$7.34 B 146,979,900.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
$0.96 B 19,250,600.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
$1.23 B 24,739,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$3.96 B 79,207,900.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
$3.45 M 69,060.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA